[
Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr; International Diabetes Federation Task Force on Epidemiology and Prevention; Hational Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120, 1640–1645, 2009.
]Search in Google Scholar
[
Arnaldi G, Mancini T, Polenta B, Boscaro M. Cardiovascular risk in Cushing’s syndrome. Pituitary 7, 253–256, 2004.
]Search in Google Scholar
[
Barahona MJ, Sucunza N, Resmini E, Fernandez-Real JM, Ricart W, Moreno-Navarrete JM, Puig T, Farrerons J, Webb SM. Persistent body fat mass and inflammatory marker increases after long-term cure of Cushing’s syndrome. J Clin Endocrinol Metab 94, 3365–3371, 2009.
]Search in Google Scholar
[
Barahona MJ, Resmini E, Vilades D, Pons-Llado G, Leta R, Puig T, Webb SM. Coronary artery disease detected by multislice computed tomography in patients after long-term cure of Cushing’s syndrome. J Clin Endocrinol Metab 98, 1093–1109, 2013.
]Search in Google Scholar
[
Biering H, Knappe G, Gerl H, Lochs H. Prevalence of diabetes in acromegaly and Cushing syndrome. Acta Med Austriaca 27, 27–31, 2000.
]Search in Google Scholar
[
Bolland MJ, Holdaway IM, Berkeley JE, Lim S, Dransfield WJ, Conaglen JV, Croxson MS, Gamble GD, Hunt PJ, Toomath RJ. Mortality and morbidity in Cushing’s syndrome in New Zealand. Clin Endocrinol 75, 436–442, 2011.
]Search in Google Scholar
[
Clayton RN, Jones PW, Reulen RC, Stewart PM, Hassan-Smith ZK, Ntali G, Karavitaki N, Dekkers OM, Pereira AM, Bolland M, Holdaway I, Lindholm J. Mortality in patients with Cushing’s disease more than 10 years after remission: a multicentre, multinational, retrospective cohort study. Lancet Diabetes Endocrinol 4, 569–576, 2016.
]Search in Google Scholar
[
Colao A, Pivonello R, Spiezia S, Faggiano A, Ferone D, Filippella M, Marzullo P, Cerbone G, Siciliani M, Lombardi G. Persistence of increased cardiovascular risk in patients with Cushing’s disease after five years of successful cure. J Clin Endocrinol Metab 84, 2664–2672, 1999.
]Search in Google Scholar
[
Dekkers OM, Horvath-Puho E, Jorgensen JO, Cannegieter SC, Ehrenstein V, Vandenbroucke JP, Pereira AM, Sorensen HT. Multisystem morbidity and mortality in Cushing’s syndrome: a cohort study. J Clin Endocrinol Metab 98, 2277–2284, 2013.
]Search in Google Scholar
[
Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 27, s5–s10, 2004.
]Search in Google Scholar
[
El Ati J, Traissac P, Delpeuch F, Aounallah-Skhiri H, Beji C, Eymard-Duvernay S, Bougatef S, Kolsteren P, Maire B, Ben Romdhane H. Gender obesity inequities are huge but differ greatly according to environment and socioeconomics in a north African setting: a national cross - sectional study in Tunisia. Plos One 7, e48153, 2012.
]Search in Google Scholar
[
Elasmi M, Feki M, Sanhaji H, Jemaa R, Haj Taeib S, Omar S, Mebazaa A, El Anti J, Hsairi M, Kaabachi N. Prevalence of conventional cardiovascular risk factors in the Great Tunis population. Rev Epidemiol Sante Publique 57, 87–92, 2009.
]Search in Google Scholar
[
Etxabe J, Vazquez JA. Morbidity and mortality in Cushing’s disease: an epidemiological approach. Clin Endocrinol 40, 479–484, 1994.
]Search in Google Scholar
[
Faggiano A, Pivonello R, Spiezia S, De Martino MC, Filippella M, Di Somma C, Lombardi G, Colao A. Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing’s disease during active disease and 1 year after disease remission. J Clin Endocrinol Metab 88, 2527–2533, 2003.
]Search in Google Scholar
[
Feelders RA, Pulgar SJ, Kempel A, Periera AM. The burden of Cushing’s disease: clinical and health-related quality of life aspects. Eur J Endocrinol 167, 311–326, 2012.
]Search in Google Scholar
[
Geer EB, Shen W, Strohmayer E, Post KD, Freda PU. Body composition and cardiovascular risk markers after remission of Cushing’s disease: a prospective study using whole-body MRI. J Clin Endocrinol Metab 97, 1702–1711, 2012.
]Search in Google Scholar
[
Giordano R, Picu A, Marinazzo E, D’Angelo V, Berardelli R, Karamouzis I, Forno D, Zinna D, Maccario M, Ghigo E, Arvat E. Metabolic and cardiovascular outcomes in patients with Cushing’s syndrome of different aetiologies during active disease and 1 year after remission. Clin Endocrinol 75, 354–360, 2011.
]Search in Google Scholar
[
Gomez RM, Albiger NM, Diaz AG, Moncet D, Pitoia FA, Bruno OD. Effect of hypercortisolism control on high blood pressure in Cushing’s syndrome. Medicina 67, 439–444, 2007.
]Search in Google Scholar
[
Hassan-Smith ZK, Sherlock M, Reulen RC, Arlt W, Ayuk J, Toogood AA, Cooper MS, Johnson AP, Stewart PM. Outcome of Cushing’s disease following transsphenoidal surgery in a single center over 20 years. J Clin Endocrinol Metab 97, 1194–201, 2012.
]Search in Google Scholar
[
Li D, El Kawkgi OM, Henriquez AF, Bancos I. Cardiovascular risk and mortality in patients with active and treated hypercortisolism. Gland Surg 9, 43–58, 2020.
]Search in Google Scholar
[
Lindholm J, Juul S, Jorgensen JO, Astrup J, Bjerre P, Feldt-Rasmussen U, Hagen C, Jorgensen J, Kosteljanetz M, Kristensen L, Laurberg P, Schmidt K, Weeke J. Incidence and late prognosis of Cushing’s syndrome: a population-based study. J Clin Endocrinol Metab 86, 117–123, 2001.
]Search in Google Scholar
[
Mancini T, Kola B, Manterot F, Boscaro M, Arnaldi G. High cardiovascular risk in patients with Cushing’s syndrome according to 1999 WHO/ISH guidelines. Clin Endocrinol 64, 768–777, 2004.
]Search in Google Scholar
[
Marzouk-Aissi W, Alaya-Bouafif NB, Bougatef S, Traissac P, Delpeuch F, Romdhane HB. Prevalence et determinants de l’hypertension arterielle chez les adultes tunisiens, Tunisie. Rev Epidemiol Sante Publique 60, S101, 2012.
]Search in Google Scholar
[
Mazziotti G, Gazzaruso C, Giustina A. Diabetes in Cushing syndrome: basic and clinical aspects. Trends Endocrinol Metab 22, 499–506, 2011.
]Search in Google Scholar
[
Pivonello R, De Leo M, Vitale P, Cozzolino A, Simeoli C, De Martino MC, Lombardi G, Colao A. Pathophysiology of diabetes mellitus in Cushing’s syndrome. Neuroendocrinology 92 Suppl 1, 77–81, 2010.
]Search in Google Scholar
[
Resmini E, Minuto F, Colao A, Ferone D. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities. Acta Diabetol 46, 85–95, 2009.
]Search in Google Scholar
[
Sippel RS, Elaraj DM, Kebebew E, Lindsay S, Tyrrell JB, Duh QY. Waiting for change: symptom resolution after adrenalectomy for Cushing’s syndrome. Surgery 144, 1054–1060, 2008.
]Search in Google Scholar
[
Valassi E, Santos A, Yaneva M, Toth M, Strasburger CJ, Chanson P, Wass JA, Chabre O, Pfeifer M, Feelders RA, Tsagarakis S, Trainer PJ, Franz H, Zopf K, Zacharieva S, Lamberts SW, Tabarin A, Webb SM; ERCUSYN Study Group. The European Registry on Cushing’s syndrome: 2-year experience. Baseline demographic and clinical characteristics. Eur J Endocrinol 165, 383–392, 2011.
]Search in Google Scholar
